《用于治疗血吸虫病的吡喹酮纳米颗粒制剂》的勘误
Correction to "Praziquantel Nanoparticle Formulation for the Treatment of Schistosomiasis".
作者信息
Mengarda Ana C, Iles Bruno, Rodrigues Vinícius C, do Nascimento Ana L L, Machado Victoria P, Reatgui Walberson S, Bento Patrícia S, Radichi Marina A, Silva Taís C, Teixeira Fernanda S, Salvadori Maria C, Simões Marina M, Paiva Karen L R, Grisolia Cesar K, Fascinelli Maria L, Silva Sebastião W, Cunha-Filho Marcílio S S, Bao Sônia N, Longo João P F, de Moraes Josué
出版信息
ACS Appl Nano Mater. 2025 Jun 6;8(22):11730. doi: 10.1021/acsanm.5c02476.
Abstract
[This corrects the article DOI: 10.1021/acsanm.4c06757.].
摘要
[本文更正了文章的数字对象标识符：10.1021/acsanm.4c06757。]
相似文献
1
Correction to "Praziquantel Nanoparticle Formulation for the Treatment of Schistosomiasis".《用于治疗血吸虫病的吡喹酮纳米颗粒制剂》的勘误
ACS Appl Nano Mater. 2025 Jun 6;8(22):11730. doi: 10.1021/acsanm.5c02476.
2
Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: research and development of a pediatric formulation of praziquantel.制定针对6岁以下血吸虫病患儿的综合治疗方案：吡喹酮儿科制剂的研发
Infect Dis Poverty. 2017 Aug 3;6(1):122. doi: 10.1186/s40249-017-0336-9.
3
Orphan Formulations in Pediatric Schistosomiasis Treatment: Development and Characterization of Praziquantel Nanoparticle-Loaded Powders for Reconstitution.儿科血吸虫病治疗中的孤儿制剂：载吡喹酮纳米粒子粉末的开发和特性研究。
AAPS PharmSciTech. 2019 Oct 16;20(8):318. doi: 10.1208/s12249-019-1548-z.
4
Paediatric schistosomiasis: last mile preparations for deploying paediatric praziquantel.儿童血吸虫病：部署儿童用吡喹酮的最后准备工作。
Trends Parasitol. 2024 Aug;40(8):687-695. doi: 10.1016/j.pt.2024.06.011. Epub 2024 Jul 19.
5
Schistosomiasis therapeutics: whats in the pipeline?血吸虫病治疗药物：正在研发的有哪些？
Expert Rev Clin Pharmacol. 2016;9(2):157-60. doi: 10.1586/17512433.2015.1102051. Epub 2015 Oct 27.
6
Correction: praziquantel and schistosomiasis treatment.更正：吡喹酮与血吸虫病治疗。
Ann Intern Med. 1983 Oct;99(4):574. doi: 10.7326/0003-4819-99-4-574_4.
7
The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).我们对吡喹酮（外消旋体和 R-对映异构体）的药代动力学和药效动力学的了解甚少。
J Antimicrob Chemother. 2014 Apr;69(4):863-70. doi: 10.1093/jac/dkt491. Epub 2014 Jan 2.
8
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis.吡喹酮和青蒿素衍生物治疗和预防人体血吸虫病的疗效：系统评价和荟萃分析。
Parasit Vectors. 2011 Oct 17;4:201. doi: 10.1186/1756-3305-4-201.
9
Correction to "Sonochemical Formation of Fluorouracil Nanoparticles: Toward Controlled Drug Delivery from Polymeric Surfaces".对“氟尿嘧啶纳米颗粒的声化学形成：从聚合物表面实现可控药物递送”的修正
ACS Appl Nano Mater. 2024 Dec 7;7(24):28885. doi: 10.1021/acsanm.4c06658. eCollection 2024 Dec 27.
10
Correction to Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin.《肠道冠状病毒多靶点抑制剂的修正：基于姜黄素的抗病毒阳离子碳点》
ACS Appl Nano Mater. 2020 May 22;3(5):4913. doi: 10.1021/acsanm.0c00970. Epub 2020 Apr 24.
引用本文的文献
1
Cubebin, a Lignan Isolated from , Exhibits Potent and Selective Antiparasitic Activity against.从[来源]中分离出的木脂素荜澄茄脂素对[对象]表现出强效且选择性的抗寄生虫活性。 （注：原文中“from”和“against”后面的内容缺失）
ACS Omega. 2025 Jul 11;10(28):31161-31169. doi: 10.1021/acsomega.5c05451. eCollection 2025 Jul 22.
2
Pluronic P123/L64 Mixed Micelles as Immediate Release Systems to Enhance the Bioavailability of Praziquantel in Rats.普朗尼克P123/L64混合胶束作为速释系统以提高大鼠体内吡喹酮的生物利用度
Int J Nanomedicine. 2025 Jul 7;20:8861-8871. doi: 10.2147/IJN.S520910. eCollection 2025.
Zotero 插件